002370 亚太药业
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0064612,333
固定资产289,304-1.84%294,714338,079364,755384,499
在建工程1,0516,468.75%1629340
无形资产42,713-2.93%44,00154,19559,20657,222
商誉0--0000
其他非流动资产41,761-2.22%42,71154,30549,55364,977
374,829-1.73%381,442446,608474,193519,030

流动资产
货币资金586,462-5.21%618,719743,851720,475757,617
应收账款95,5964.57%91,41695,31079,51089,059
存货100,943-5.88%107,25170,12989,47595,205
其他流动资产75,056-7.21%80,88845,87265,72162,965
858,057-4.48%898,274955,160955,1801,004,845

流动负债
短期借款0--030,05650,06050,061
应付票据60,3120.00%60,31202,32030,370
应付帐款16,523-62.15%43,65545,76549,47759,461
其他流动负债31,695-34.34%48,270340,61659,94782,491
108,531-28.71%152,237416,436161,803222,383
流动资产净值749,5260.47%746,038538,724793,377782,462
资产总额减流动负债1,124,356-0.28%1,127,479985,3321,267,5711,301,492

非流动负债
长期借款0--0000
应付债券0--00639,477900,015
其他非流动负债6,653-7.49%7,19213,15147,220100,211
6,653-7.49%7,19213,151686,6961,000,226

总权益
    实收股本745,6680.00%745,668728,586609,171536,687
    储备项目372,035-0.69%374,619243,595(28,297)(235,420)
股东权益1,117,702-0.23%1,120,287972,181580,874301,267
非控股权益0--0000